CCOC(=O)N1CCN(C(=O)c2cn(CC)c3cc(N4CCN(C)CC4)c(F)cc3c2=O)CC1.Cl
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?